Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis (Q92242280)
Jump to navigation
Jump to search
scientific article published on 01 January 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis |
scientific article published on 01 January 2020 |
Statements
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis (English)
Frank Hoentjen